Institutional investors purchased a net $2.2 million shares of MDCO during the quarter ended June 2015 and now own 112.35% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PARTNER FUND MANAGEMENT LP Bought 1.3 Million shares of Medicines Co
CORVEX MANAGEMENT LP Bought 1.1 Million shares of Medicines Co
RA CAPITAL MANAGEMENT LLC Bought 705.9 Thousand shares of Medicines Co